Merck to Continue Focus on Cancer Drug Keytruda

Merck & Co. intends to push its key drug Keytruda to be used for more types of cancer and will file a new-drug application for its hepatitis C treatment this year.



from WSJ.com: US Business http://ift.tt/1DAtauU

via IFTTT